On February 20, 2026 Pulse Biosciences approved inducement grants under Nasdaq Listing Rule 5635(c)(4), issuing equity awards comprising stock options exercisable at the closing market price on grant date and restricted stock units. These awards are tied to newly hired executives and vest over a four-year period, increasing the potential share count upon full vesting.